MGNX (Macrogenics) Cyclically Adjusted Book per Share: $5.39 (As of Mar. 2026)


MGNX Macrogenics Inc MGNX
47 GF Score
Price $4.57
GF Value $4.06
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Macrogenics Cyclically Adjusted Book per Share?

Macrogenics MGNX -1.93% 47 Cyclically Adjusted Book per Share is $5.39 as of Mar. 2026. GuruFocus rates MGNX with a GF Score™ of 47/100 and a GF Value™ of $4.06 (Modestly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Macrogenics's adjusted book value per share for the three months ended in Mar. 2026 was $0.334. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $5.39 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Macrogenics's average Cyclically Adjusted Book Growth Rate was -14.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Macrogenics was -5.20% per year. The lowest was -5.20% per year. And the median was -5.20% per year.

As of today (2026-07-09), Macrogenics's current stock price is $4.57. Macrogenics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $5.39. Macrogenics's Cyclically Adjusted PB Ratio of today is 0.85.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Macrogenics was 2.82. The lowest was 0.17. And the median was 0.64.


Macrogenics  (NAS:MGNX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Macrogenics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.57/5.39
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Macrogenics was 2.82. The lowest was 0.17. And the median was 0.64.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Macrogenics Cyclically Adjusted Book per Share Related Terms


Macrogenics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Macrogenics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Macrogenics Cyclically Adjusted Book per Share Chart

Macrogenics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 6.53 6.75 6.44 5.56

Macrogenics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.30 6.13 5.87 5.56 5.39

MGNX vs IMRX, TRDA, SLNCF: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Macrogenics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Macrogenics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Macrogenics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Macrogenics's Cyclically Adjusted PB Ratio falls into.


MGNX
47GF Score
Macrogenics Inc MGNX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Macrogenics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Macrogenics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.334/330.2130*330.2130
=0.334

Current CPI (Mar. 2026) = 330.2130.

Macrogenics Quarterly Data

Book Value per Share CPI Adj_Book
201606 9.511 241.018 13.031
201609 8.620 241.428 11.790
201612 7.707 241.432 10.541
201703 6.708 243.801 9.086
201706 6.307 244.955 8.502
201709 5.148 246.819 6.887
201712 8.118 246.524 10.874
201803 6.679 249.554 8.838
201806 7.389 251.989 9.683
201809 6.690 252.439 8.751
201812 5.735 251.233 7.538
201903 6.569 254.202 8.533
201906 6.022 256.143 7.763
201909 5.217 256.759 6.709
201912 4.711 256.974 6.054
202003 3.879 258.115 4.963
202006 4.643 257.797 5.947
202009 5.191 260.280 6.586
202012 5.261 260.474 6.670
202103 5.841 264.877 7.282
202106 5.306 271.696 6.449
202109 4.758 274.310 5.728
202112 3.908 278.802 4.629
202203 2.906 287.504 3.338
202206 2.318 296.311 2.583
202209 2.001 296.808 2.226
202212 2.302 296.797 2.561
202303 1.767 301.836 1.933
202306 2.770 305.109 2.998
202309 3.127 307.789 3.355
202312 2.459 306.746 2.647
202403 1.697 312.332 1.794
202406 0.922 314.175 0.969
202409 1.913 315.301 2.003
202412 1.847 315.605 1.932
202503 1.254 319.799 1.295
202506 0.738 322.561 0.756
202509 1.059 324.800 1.077
202512 0.878 324.054 0.895
202603 0.334 330.213 0.334

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $5.39 mean?
Macrogenics (MGNX) has a Cyclically Adjusted Book per Share of $5.39 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Macrogenics and its competitors.
Is Macrogenics' Cyclically Adjusted Book per Share too high?
Macrogenics' current Cyclically Adjusted Book per Share is $5.39. Overall, Macrogenics has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Macrogenics' Cyclically Adjusted Book per Share compare to IMRX and TRDA?
Macrogenics' Cyclically Adjusted Book per Share of $5.39 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Macrogenics and its competitors. Macrogenics's current Cyclically Adjusted Book per Share is $5.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macrogenics stock overvalued right now?
Based on GuruFocus' analysis, Macrogenics (MGNX) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.06, compared to a current price of $4.57 — trading 12.6% above its estimated fair value. The current Cyclically Adjusted Book per Share is $5.39. Macrogenics' overall GF Score™ is 47/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Macrogenics (MGNX), the current Cyclically Adjusted Book per Share is $5.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Macrogenics (MGNX) Overvalued in 2026?

Based on GuruFocus' analysis, Macrogenics stock appears to be overvalued. The current stock price of $4.57 is trading 12.6% above its estimated GF Value™ of $4.06. GuruFocus considers Macrogenics to be Modestly Overvalued.

Key valuation signals for MGNX:

  • Cyclically Adjusted Book per Share: $5.39
  • GF Value™: $4.06 vs. price of $4.57 (12.6% above fair value)
  • GF Score™: 47/100 with 8 warning signs

No single metric tells the full story. See the MGNX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Macrogenics Business Description

Other Exchanges M55:Germany
Address 9704 Medical Center Drive, Rockville, MD, USA, 20850
Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conjugates (ADCs) and multi-specific antibodies (which it refers to as DART and TRIDENT molecules). It is advancing three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload. Its segment is developing and commercializing monoclonal antibody-based therapeutics.
47GF Score

Get the complete analysis for MGNX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.57
Price
$4.06
GF Value